These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 30780853)

  • 1. Liraglutide Effect and Action in Diabetes (LEAD™) trial.
    Madsbad S
    Expert Rev Endocrinol Metab; 2009 Mar; 4(2):119-129. PubMed ID: 30780853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug therapy of type 2 diabetes and cardiovascular prevention: potentials for liraglutide].
    Reboldi G
    G Ital Cardiol (Rome); 2009 Jul; 10(7):434-47. PubMed ID: 19761101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide, the once-daily human GLP-1 analog, in the treatment of Type 2 diabetes.
    Hribal ML; Sesti G
    Expert Rev Endocrinol Metab; 2010 Jul; 5(4):495-505. PubMed ID: 30780808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E; Sesti G
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide: a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes mellitus.
    Joffe D
    Am J Health Syst Pharm; 2010 Aug; 67(16):1326-36. PubMed ID: 20689121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide: a new treatment for type 2 diabetes.
    Vilsboll T
    Drugs Today (Barc); 2009 Feb; 45(2):101-13. PubMed ID: 19343230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation GLP-1 therapy: an introduction to liraglutide.
    Repas T
    Postgrad Med; 2011 Sep; 123(5):239-47. PubMed ID: 21904107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies of liraglutide, a novel, once-daily human glucagon-like peptide-1 analog for improved management of type 2 diabetes mellitus.
    Drab SR
    Pharmacotherapy; 2009 Dec; 29(12 Pt 2):43S-54S. PubMed ID: 19947816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
    Bode B
    Am J Manag Care; 2011 Mar; 17(2 Suppl):S59-70. PubMed ID: 21517658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide in the treatment of Type 2 diabetes: clinical data and practical considerations for its use.
    Ampudia-Blasco FJ; Gómez CC; Claramunt XC; Alegría JG; Gimeno EJ; Bravo JJM; Raya PM; Pérez JN; Domingo MP
    Expert Rev Endocrinol Metab; 2010 Nov; 5(6):799-807. PubMed ID: 30780828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide: A Glucagon-Like Peptide-1 Agonist for Chronic Weight Management.
    Manigault KR; Thurston MM
    Consult Pharm; 2016 Dec; 31(12):685-697. PubMed ID: 28074747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide: clinical pharmacology and considerations for therapy.
    Sisson EM
    Pharmacotherapy; 2011 Sep; 31(9):896-911. PubMed ID: 21923591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pearls for initiating and utilizing liraglutide in patients with type 2 diabetes.
    Gross B
    J Pharm Pract; 2013 Apr; 26(2):144-50. PubMed ID: 23204146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide in type 2 diabetes: from pharmacological development to clinical practice.
    Rossi MC; Nicolucci A
    Acta Biomed; 2009 Aug; 80(2):93-101. PubMed ID: 19848045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor agonists for weight loss in adult patients without diabetes.
    Ottney A
    Am J Health Syst Pharm; 2013 Dec; 70(23):2097-103. PubMed ID: 24249759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from the Liraglutide Clinical Development Program--the Liraglutide Effect and Action in Diabetes (LEAD) studies.
    McGill JB
    Postgrad Med; 2009 May; 121(3):16-25. PubMed ID: 19491536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide in the treatment of obesity.
    Ng SY; Wilding JP
    Expert Opin Biol Ther; 2014 Aug; 14(8):1215-24. PubMed ID: 24905058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of liraglutide in the treatment of type 2 diabetes.
    Rigato M; Fadini GP
    Diabetes Metab Syndr Obes; 2014; 7():107-20. PubMed ID: 24672252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liraglutide].
    Takahashi T; Odawara M
    Nihon Rinsho; 2011 May; 69(5):883-9. PubMed ID: 21595276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.
    Farr OM; Sofopoulos M; Tsoukas MA; Dincer F; Thakkar B; Sahin-Efe A; Filippaios A; Bowers J; Srnka A; Gavrieli A; Ko BJ; Liakou C; Kanyuch N; Tseleni-Balafouta S; Mantzoros CS
    Diabetologia; 2016 May; 59(5):954-65. PubMed ID: 26831302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.